Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) saw a large drop in short interest during the month of January. As of January 30th, there was short interest totaling 6,028 shares, a drop of 76.2% from the January 15th total of 25,312 shares. Based on an average daily volume of 11,893 shares, the short-interest ratio is presently 0.5 days. Currently, 0.5% of the shares of the company are sold short. Currently, 0.5% of the shares of the company are sold short. Based on an average daily volume of 11,893 shares, the short-interest ratio is presently 0.5 days.
Institutional Investors Weigh In On Global X HealthTech ETF
Several large investors have recently added to or reduced their stakes in HEAL. Glenmede Investment Management LP purchased a new stake in Global X HealthTech ETF during the third quarter valued at about $31,000. AE Wealth Management LLC purchased a new position in shares of Global X HealthTech ETF in the third quarter worth about $34,000. Banque Cantonale Vaudoise bought a new stake in shares of Global X HealthTech ETF in the third quarter valued at approximately $37,000. EverSource Wealth Advisors LLC raised its position in shares of Global X HealthTech ETF by 26,522.2% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,396 shares of the company’s stock valued at $70,000 after purchasing an additional 2,387 shares during the period. Finally, Farther Finance Advisors LLC purchased a new stake in shares of Global X HealthTech ETF during the 4th quarter valued at approximately $111,000.
Global X HealthTech ETF Trading Down 3.7%
Global X HealthTech ETF stock opened at $25.24 on Friday. The business’s 50 day simple moving average is $29.54 and its 200 day simple moving average is $30.89. Global X HealthTech ETF has a 12 month low of $24.48 and a 12 month high of $35.73. The company has a market cap of $33.57 million, a price-to-earnings ratio of 42.80 and a beta of 1.13.
Global X HealthTech ETF Dividend Announcement
Global X HealthTech ETF Company Profile
An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.
Recommended Stories
- Five stocks we like better than Global X HealthTech ETF
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Global X HealthTech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X HealthTech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
